Glenn Whaley News Today

Immunic, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.51.

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

Jessica Breu: Good morning, and welcome to Immunics First Quarter 2023 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic.

Jessica Breu: Good morning and welcome to Immunics Fourth Quarter and Year End 2022 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic.

Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q2 2022 Earnings Conference Call August 4, 2022 08:00 ET Company Participants Jessica Breu - Head, Investor Relations and Communications Daniel Vitt -...

Immunic, Inc. (NASDAQ:IMUX – Get Rating) CFO Glenn Whaley bought 3,500 shares of the company’s stock in a transaction dated Friday, June 3rd. The stock was acquired at an average price of $3.04 per share, for a total transaction of $10,640.00. Following the acquisition, the chief financial officer now directly owns 12,568 shares in the […]

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...

Immunic Inc. (NASDAQ:NASDAQ:IMUX) Q1 2022 Earnings Conference Call May 10, 2022, 8:00 AM ET Company Participants Daniel Vitt – Chief Executive officer, President & Director Glenn Whaley...

The following discussion and analysis of financial condition and results of operations should be read in conjunction with our unaudited interim condensed consolidated financial statements and notes... | May 10, 2022

DGAP-News: Immunic, Inc. / Key word(s): Personnel Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer 16.03.2022 / 11:30 The issuer is solely responsible